应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PLYX Polaryx Therapeutics, Inc.
休市中 02-06 16:00:00 EST
8.91
-7.09
-44.31%
盘后
8.47
-0.44
-4.95%
19:52 EST
最高
17.20
最低
7.35
成交量
18.88万
今开
17.20
昨收
16.00
日振幅
61.56%
总市值
4.22亿
流通市值
4.22亿
总股本
4,734万
成交额
168.51万
换手率
0.40%
流通股本
4,734万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Polaryx Therapeutics 宣布直接登陆纳斯达克,股票代码“PLYX”即将开始交易
美股速递 · 02-02
Polaryx Therapeutics 宣布直接登陆纳斯达克,股票代码“PLYX”即将开始交易
加载更多
公司概况
公司名称:
Polaryx Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Polaryx Therapeutics, Inc.最初于2014年8月22日在怀俄明州注册成立。2025年10月24日,公司完成了重新注册过程,转为内华达州公司。Polaryx是一家临床阶段的生物技术公司,致力于发现、开发和商业化针对罕见儿童溶酶体储积病(LSDs)的创新疗法。公司采用多模式治疗方法,结合小分子药物疗法和基因疗法,旨在解决这些疾病的遗传原因和下游影响。其领先的药物候选产品PLX-200,针对多种LSDs,并已进入临床试验阶段。Polaryx的药物开发战略以提供安全、有效、以患者为中心的治疗方案为核心,旨在满足这些疾病尚未解决的重大需求。
发行价格:
--
{"stockData":{"symbol":"PLYX","market":"US","secType":"STK","nameCN":"Polaryx Therapeutics, Inc.","latestPrice":8.91,"timestamp":1770411600000,"preClose":16,"halted":0,"volume":188813,"hourTrading":{"tag":"盘后","latestPrice":8.4692,"preClose":8.91,"latestTime":"19:52 EST","volume":8343,"amount":71693.3642,"timestamp":1770425529825,"change":-0.4408,"changeRate":-0.049473,"amplitude":0.08193},"delay":0,"changeRate":-0.443125,"floatShares":47343297,"shares":47343297,"eps":0,"marketStatus":"休市中","change":-7.09,"latestTime":"02-06 16:00:00 EST","open":17.2,"high":17.2,"low":7.35,"amount":1685070.4927110001,"amplitude":0.615625,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"listingDate":1769749200000,"exchange":"NASDAQ","adjPreClose":16,"preHourTrading":{"tag":"盘前","latestPrice":17,"preClose":16.25,"latestTime":"09:28 EST","volume":393,"amount":6644.939498999999,"timestamp":1770388082496,"change":0.75,"changeRate":0.046154,"amplitude":0.159385},"postHourTrading":{"tag":"盘后","latestPrice":8.4692,"preClose":8.91,"latestTime":"19:52 EST","volume":8343,"amount":71693.3642,"timestamp":1770425529825,"change":-0.4408,"changeRate":-0.049473,"amplitude":0.08193},"volumeRatio":6.449738204275908},"requestUrl":"/m/hq/s/PLYX","defaultTab":"news","newsList":[{"id":"1138471055","title":"Polaryx Therapeutics 宣布直接登陆纳斯达克,股票代码“PLYX”即将开始交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1138471055","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138471055?lang=zh_cn&edition=full","pubTime":"2026-02-02 21:33","pubTimestamp":1770039190,"startTime":"0","endTime":"0","summary":"Polaryx Therapeutics 已正式宣布,公司将通过直接上市方式登陆纳斯达克交易所。其普通股预计将于近期开始公开交易,股票交易代码定为“PLYX”。此次直接挂牌意味着该公司不发行新股,而是由现有股东直接将其持有的股份在公开市场进行交易。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLYX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.polaryx.com","stockEarnings":[{"period":"1week","weight":-0.802},{"period":"ytd","weight":-0.802}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0293},{"period":"6month","weight":0.0839},{"period":"1year","weight":0.139},{"period":"ytd","weight":0.0128}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Polaryx Therapeutics, Inc.最初于2014年8月22日在怀俄明州注册成立。2025年10月24日,公司完成了重新注册过程,转为内华达州公司。Polaryx是一家临床阶段的生物技术公司,致力于发现、开发和商业化针对罕见儿童溶酶体储积病(LSDs)的创新疗法。公司采用多模式治疗方法,结合小分子药物疗法和基因疗法,旨在解决这些疾病的遗传原因和下游影响。其领先的药物候选产品PLX-200,针对多种LSDs,并已进入临床试验阶段。Polaryx的药物开发战略以提供安全、有效、以患者为中心的治疗方案为核心,旨在满足这些疾病尚未解决的重大需求。","exchange":"NASDAQ","name":"Polaryx Therapeutics, Inc.","nameEN":"Polaryx Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Polaryx Therapeutics, Inc.(PLYX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Polaryx Therapeutics, Inc.(PLYX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Polaryx Therapeutics, Inc.,PLYX,Polaryx Therapeutics, Inc.股票,Polaryx Therapeutics, Inc.股票老虎,Polaryx Therapeutics, Inc.股票老虎国际,Polaryx Therapeutics, Inc.行情,Polaryx Therapeutics, Inc.股票行情,Polaryx Therapeutics, Inc.股价,Polaryx Therapeutics, Inc.股市,Polaryx Therapeutics, Inc.股票价格,Polaryx Therapeutics, Inc.股票交易,Polaryx Therapeutics, Inc.股票购买,Polaryx Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Polaryx Therapeutics, Inc.(PLYX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Polaryx Therapeutics, Inc.(PLYX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}